2021
DOI: 10.1016/j.medengphy.2020.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Gait analysis in neurological populations: Progression in the use of wearables

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
70
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1
1

Relationship

2
7

Authors

Journals

citations
Cited by 108 publications
(84 citation statements)
references
References 243 publications
(255 reference statements)
0
70
0
Order By: Relevance
“…An IMU including a triaxial accelerometer (Q'z TAG Walk; Sumitomo Electric Industries Ltd., Osaka, Japan) was used to measure trunk acceleration during gait. The IMU was positioned over the third lumbar vertebra (L3) and secured to the subject using an elastic band according to previous studies [ 2 , 4 , 9 ]. The x , y , and z -axes of the accelerometer corresponded to the mediolateral, anteroposterior, and vertical directions, respectively.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…An IMU including a triaxial accelerometer (Q'z TAG Walk; Sumitomo Electric Industries Ltd., Osaka, Japan) was used to measure trunk acceleration during gait. The IMU was positioned over the third lumbar vertebra (L3) and secured to the subject using an elastic band according to previous studies [ 2 , 4 , 9 ]. The x , y , and z -axes of the accelerometer corresponded to the mediolateral, anteroposterior, and vertical directions, respectively.…”
Section: Methodsmentioning
confidence: 99%
“…Trunk acceleration measurement by IMU during gait represents the characteristics of walking and is useful to identify gait abnormalities [7]. IMUs can be used not only for calculating important gait parameters, such as spatiotemporal parameters [8][9][10], or for investigating the gait stability and variability between normal and pathological gaits but also for classifying different types of gait patterns, for example, the stroke patient gait pattern [11] or Parkinson's disease gait pattern [12]. These benefits have led to gait analysis with IMUs being widely used in clinical settings and care units.…”
Section: Introductionmentioning
confidence: 99%
“…Thus, both walkways and motion capturing systems are only suitable for measurements in clinical settings or other controlled environments. A less restrictive option are wearable sensors [ 20 ] for gait tracking [ 21 , 22 ].…”
Section: Introductionmentioning
confidence: 99%
“…Currently, there is no de nitive way of objectively understanding the reasons for lack of differences in free-living gait between our chronic mTBI and healthy control cohorts, as there are many unknown factors that affect free-living assessments. For example, not knowing the environments people were regularly walking in, the surfaces they walked on, or the types of terrain encountered [54]. Equally, it is not possible to quantify the usual free-living mobility habits of the participants or if this cohort display any compensatory behaviour strategies (e.g.…”
Section: Free Living Gait Characteristics Are Not Impaired In Chronicmentioning
confidence: 99%